Literature DB >> 5920652

Allopurinol in treatment of gout.

J T Scott, A P Hall, R Grahame.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5920652      PMCID： PMC1943105          DOI： 10.1136/bmj.2.5509.321

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  20 in total

1.  4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.

Authors:  A P HALL; V P HOLLOWAY; J T SCOTT
Journal:  Ann Rheum Dis       Date:  1964-11       Impact factor: 19.103

2.  [TREATMENT OF GOUTY DYSPURINIA BY PARAMETABOLITES AND, ESPECIALLY, BY A XANTHINE OXIDASE INHIBITOR].

Authors:  F DELBARRE; C AUSCHER; C LABROUSSE; D E GERYA
Journal:  Presse Med       Date:  1965-05-01       Impact factor: 1.228

3.  THE RENAL EXCRETION OF OXYPURINES.

Authors:  S GOLDFINGER; J R KLINENBERG; J E SEEGMILLER
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

4.  RETICULOCYTE COUNT IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH OBSERVATIONS ON THE EFFECT OF GOLD THERAPY ON BONE MARROW FUNCTION.

Authors:  A M DENMAN; H HUBER; P H WOOD; J T SCOTT
Journal:  Ann Rheum Dis       Date:  1965-05       Impact factor: 19.103

5.  The old and new concepts of acute gouty arthritis.

Authors:  J E SEEGMILLER; R R HOWELL
Journal:  Arthritis Rheum       Date:  1962-12

6.  Allopurinol in the treatment of gout.

Authors:  R W Rundles; E N Metz; H R Silberman
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

7.  Studies with allopurinol (HPP) in patients with tophaceous gout.

Authors:  C J Smyth
Journal:  Arthritis Rheum       Date:  1965-10

8.  [Allopurinol (HPP) in the treatment of gout and hyperuricemia due to thiazide diuretics].

Authors:  A Rapado Errazti
Journal:  Rev Clin Esp       Date:  1965-07-31       Impact factor: 1.556

9.  Haemosiderosis associated with xanthine oxidase inhibition.

Authors:  L W Powell; B T Emmerson
Journal:  Lancet       Date:  1966-01-29       Impact factor: 79.321

10.  Allopurinal and acute uric acid nephropathy.

Authors:  R W Watts; P J Watkins; J Q Matthias; D A Gibbs
Journal:  Br Med J       Date:  1966-01-22
View more
  11 in total

1.  Allopurinol-hypersensitivity vasculitis and liver damage.

Authors:  T D Boyer; N Sun; T B Reynolds
Journal:  West J Med       Date:  1977-02

2.  Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

Authors:  Garry G Graham; Diluk R W Kannangara; Sophie L Stocker; Ian Portek; Kevin D Pile; Praveen L Indraratna; Indira Datta; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

3.  Withdrawal of allopurinol in patients with gout.

Authors:  W Y Loebl; J T Scott
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

4.  Uric acid excretion and surgery.

Authors:  M L Snaith; J T Scott
Journal:  Ann Rheum Dis       Date:  1972-05       Impact factor: 19.103

5.  Uses of allopurinol.

Authors: 
Journal:  Br Med J       Date:  1971-10-23

6.  Sulphobromophthalein retention in gout and asymptomatic hyperuricaemia.

Authors:  R Grahame; R M Haslam; J T Scott
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

7.  Long-term use of allopurinol in the treatment of gout.

Authors:  G D Kersley
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

8.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 9.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

10.  Allopurinol.

Authors: 
Journal:  Br Med J       Date:  1967-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.